Nigella sativa L. as a potential natural product for the treatment of COVID-19
Last updated: 01 Jan 2025
10.21608/ejchem.2022.111517.5069
COVID-19, SARS-COV2, Nigella Sativa, natural products, World health organization, pandemic
Khaldun
Al Azzam
Pharmacological and Diagnostic Research Center (PDRC), Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan
azzamkha@yahoo.com
Amman
0000-0003-4097-6991
Rima
Al Omari
Mohammad
Pharmacological and Diagnostic Research Center (PDRC), Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan
r.alomari@ammanu.edu.jo
Amman
0000-0002-4661-656X
Adam
aburoub
Pharmacological and Diagnostic Research Center (PDRC), Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan
a.aburoub@ammanu.edu.jo
Amman
Lyazzat
Bekbayeva
Biology Program, School of Distance Education, Universiti Sains Malaysia, Penang, Malaysia
lyazzat_bk2019@mail.ru
Almaty
0000-0002-0804-1259
El-Sayed
Negim
Moussa
Laboratory of Advanced Materials and Technology, Kazakh-British Technical University, 59 Tole bi St., 050000, Almaty, Kazakhstan
elashmawi5@yahoo.com
Almaty
0000-0002-4370-8995
Hassan
aboulenein
Pharmaceutical and Medicinal Chemistry Department, National Research Centre, Dokki, Giza 12311, Egypt
haboulenein@yahoo.com
cairo
0000-0003-0249-7009
65
10
34864
2022-10-01
2021-12-16
2022-10-01
141
151
0449-2285
2357-0245
https://ejchem.journals.ekb.eg/article_221039.html
https://ejchem.journals.ekb.eg/service?article_code=221039
13
Review Articles
444
Journal
Egyptian Journal of Chemistry
https://ejchem.journals.ekb.eg/
Nigella sativa L. as a potential natural product for the treatment of COVID-19
Details
Type
Article
Created At
22 Jan 2023